Arrhythmias in patients with ventricular assist devices

Current Opinion in Cardiology

Volumn 27, Issue 1, 2012, Pages 13-18

  Boyle, Andrew ^a  

^a ST LUKE S MEDICAL CENTER   (United States)

Author keywords

assisted circulation; atrial fibrillation; heart assist devices; ventricular tachycardia

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOFETILIDE; METOPROLOL TARTRATE;

ARTIFICIAL VENTILATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; DEFIBRILLATION; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART OUTPUT; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE TACHYCARDIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE; MITRAL VALVE REGURGITATION; PALLIATIVE THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE GENERATOR; REVIEW; RIGHT VENTRICULAR ASSIST DEVICE; SUDDEN DEATH; SURVIVAL; SYNCOPE; THROMBOEMBOLISM; TRICUSPID VALVE REGURGITATION;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; RISK FACTORS;

EID: 83055170874     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32834d84fd     Document Type: Review

References (12)

1. Miller L, Pagani F, Russell S, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357:885-896. (Pubitemid 47347322)
2. Slaughter M, Rogers J, Milano C, et al. Advanced heart failure treated with continuous-flow left ventricular device. N Engl J Med 2009; 361:2241-2251.
3. Boyle A, Ascheim D, Russo M, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by preoperative INTERMACS classification. J Heart Lung Transplant 2011; 30:402-407.
4. Starling R, Naka Y, Boyle A, et al. Results of the post-U.S. Food and Drug Administration approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation. J Am Coll Cardiol 2011; 57:1890-1898.
5. Maisel W, Stevenson L. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91 (Suppl):2D-8D. (Pubitemid 36369329)
6. Loh E, St John Sutton M, Wun C-C, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997; 336:251-257. (Pubitemid 27044626)
7. Freudenberger R, Hellkamp A, Halperin J, et al. Risk of thromboembolism in heart failure: an analysis from the sudden cardiac death in heart failure trial (SCD-HeFT). Circulation 2007; 115:2637-2641. (Pubitemid 46791362)
8. Gage B, Waterman A, Shannon W, et al. Validation of clinical classification schemes for predicting stroke. JAMA 2001; 285:2864-2870.
9. Zaman A, Archbold A, Helft G, et al. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 2000; 101:1403-1408. (Pubitemid 30169862)
10. Boyle A, Russell S, Teuteberg J, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anticoagulation. J Heart Lung Transplant 2009; 28:881-887.
11. Anderson M, Videbaek R, Boesgaard S, et al. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant 2009; 28:733-735.
12. Dandamudi G, Ghumman W, Das M, et al. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Heart Rhythm 2007; 4:1165-1169. (Pubitemid 47324123)